|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-10-8
|
|
pubmed:abstractText |
alpha-Oxoaldehydes such as glyoxal (GO), methylglyoxal (MG), and 3-deoxyglucosone (3DG) are precursors of advanced glycation end products and exert direct toxicity to cells and tissues. Plasma levels of these substances are reportedly elevated in diabetes and dialysis patients, but the data on exact levels and clinical significance in chronic kidney disease (CKD) are limited.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9670
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
871-8
|
|
pubmed:meshHeading |
pubmed-meshheading:18547947-Adult,
pubmed-meshheading:18547947-Aged,
pubmed-meshheading:18547947-Aldehydes,
pubmed-meshheading:18547947-Calibration,
pubmed-meshheading:18547947-Chromatography, High Pressure Liquid,
pubmed-meshheading:18547947-Chromatography, Liquid,
pubmed-meshheading:18547947-Diabetes Mellitus,
pubmed-meshheading:18547947-Female,
pubmed-meshheading:18547947-Glomerular Filtration Rate,
pubmed-meshheading:18547947-Humans,
pubmed-meshheading:18547947-Kidney Failure, Chronic,
pubmed-meshheading:18547947-Male,
pubmed-meshheading:18547947-Mass Spectrometry,
pubmed-meshheading:18547947-Middle Aged,
pubmed-meshheading:18547947-Renal Dialysis
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients.
|
|
pubmed:affiliation |
Research Division of Dialysis and Chronic Kidney Disease, Tohoku University Graduate School of Medicine, Sendai, Japan. keinakayama@mail.tains.tohoku.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
